Skip to main content
. 2022 Dec;13(6):3227–3239. doi: 10.21037/jgo-22-348

Figure 2.

Figure 2

Survival curves of patients treated with and without aCT. (A) Survival of matched cohort excluding mortality <30 days (N=771, P=0.7720). (B) Survival of matched cohort excluding mortality <30 days, stratified by T-stage (N=399). Log rank P=0.0984 in T1/T2, aCT vs. no aCT. Log rank P=0.0129 in T3/T4 (N=372), aCT vs. no aCT. (C) Survival of matched cohort excluding mortality <30 days, stratified according to N stage. Log rank P=0.3150 in N0 (N=487), aCT vs. no aCT. Log rank P=0.2527 in N1/N2 (N=284), aCT vs. no aCT. aCT, adjuvant chemotherapy.